Notably, PGE2 has also been shown to suppress CTLs survival, type I interferon production and cytotoxicity in vitro [21], and treatment of tumor-bearing mice with COX-2 inhibitors and PD-1 monoclonal antibody (mAb) improve antitumor immunity [22]. The gene discussed is PTGS2; the disease is neoplasm.